U.S. Markets closed

As Ironwood spinout Cyclerion launches on the Nasdaq, CEO Hecht sees 'a fresh start'

Allison DeAngelis
As Ironwood spinout Cyclerion launches on the Nasdaq, CEO Hecht sees 'a fresh start'

"To be clear, this is not a division between commercial and R-and-D priorities," new Cyclerion CEO Pete Hecht said of the split between the company he founded, Ironwood Pharmaceuticals, and his new firm.